These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15967554)

  • 1. Emotional exposure in the treatment of substance use disorders: conceptual model, evidence, and future directions.
    Otto MW; Powers MB; Fischmann D
    Clin Psychol Rev; 2005 Sep; 25(6):824-39. PubMed ID: 15967554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders.
    Wilamowska ZA; Thompson-Hollands J; Fairholme CP; Ellard KK; Farchione TJ; Barlow DH
    Depress Anxiety; 2010 Oct; 27(10):882-90. PubMed ID: 20886609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications.
    Behar E; DiMarco ID; Hekler EB; Mohlman J; Staples AM
    J Anxiety Disord; 2009 Dec; 23(8):1011-23. PubMed ID: 19700258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives.
    Arch JJ; Craske MG
    Psychiatr Clin North Am; 2009 Sep; 32(3):525-47. PubMed ID: 19716989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A laboratory-based study of the relationship between childhood abuse and experiential avoidance among inner-city substance users: the role of emotional nonacceptance.
    Gratz KL; Bornovalova MA; Delany-Brumsey A; Nick B; Lejuez CW
    Behav Ther; 2007 Sep; 38(3):256-68. PubMed ID: 17697851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulsivity as a common process across borderline personality and substance use disorders.
    Bornovalova MA; Lejuez CW; Daughters SB; Zachary Rosenthal M; Lynch TR
    Clin Psychol Rev; 2005 Sep; 25(6):790-812. PubMed ID: 16005556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review.
    Bradizza CM; Stasiewicz PR; Paas ND
    Clin Psychol Rev; 2006 Mar; 26(2):162-78. PubMed ID: 16406196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanisms for why desensitization and exposure therapy work.
    Tryon WW
    Clin Psychol Rev; 2005 Jan; 25(1):67-95. PubMed ID: 15596081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety-control strategies: is there room for neutralization in successful exposure treatment?
    Parrish CL; Radomsky AS; Dugas MJ
    Clin Psychol Rev; 2008 Dec; 28(8):1400-12. PubMed ID: 18783862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rethinking the paradigms that inform behavioral treatment research for substance use disorders.
    Morgenstern J; McKay JR
    Addiction; 2007 Sep; 102(9):1377-89. PubMed ID: 17610541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of voucher-based reinforcement therapy for substance use disorders.
    Lussier JP; Heil SH; Mongeon JA; Badger GJ; Higgins ST
    Addiction; 2006 Feb; 101(2):192-203. PubMed ID: 16445548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.
    Otto MW; Safren SA; Pollack MH
    J Anxiety Disord; 2004; 18(1):69-87. PubMed ID: 14725869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open trial of a transdiagnostic cognitive-behavioral group therapy for anxiety disorder.
    Norton PJ
    Behav Ther; 2008 Sep; 39(3):242-50. PubMed ID: 18721638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance and relationship context: a model of substance use disorder treatment outcome.
    Gifford EV; Ritsher JB; McKellar JD; Moos RH
    Addiction; 2006 Aug; 101(8):1167-77. PubMed ID: 16869846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific phobias.
    Hamm AO
    Psychiatr Clin North Am; 2009 Sep; 32(3):577-91. PubMed ID: 19716991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eating disorders and multi-level models of emotion: an integrated model.
    Fox JR; Power MJ
    Clin Psychol Psychother; 2009; 16(4):240-67. PubMed ID: 19639647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of drug use outcome expectancies in substance abuse risk: an interactional-transformational model.
    Leventhal AM; Schmitz JM
    Addict Behav; 2006 Nov; 31(11):2038-62. PubMed ID: 16616433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: I. Clinical implications.
    Lara DR; Pinto O; Akiskal K; Akiskal HS
    J Affect Disord; 2006 Aug; 94(1-3):67-87. PubMed ID: 16730070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety, panic and adult asthma: a cognitive-behavioral perspective.
    Deshmukh VM; Toelle BG; Usherwood T; O'Grady B; Jenkins CR
    Respir Med; 2007 Feb; 101(2):194-202. PubMed ID: 16781132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.